William Huyett, Chief Financial Officer at Cyclerion Therapeutics, Inc. (CYCN), sold 3,922 shares at $2.05 ($8K) on 2019-11-08, disclosed to the SEC on 2019-11-12.
Scheduled sale ($8k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CYCN | SELL | 2020-02-25 | $18K | — | Filing → |